COUGAR BIOTECHNOLOGY INC has a total of 32 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in Japan, Republic of Korea and Israel. Its main competitors in its focus markets pharmaceuticals are REVEN IP HOLDCO LLC, GT BIOPHARMA INC and MARKOV IHOR SEMENOVYCH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 5 | |
#2 | Republic of Korea | 5 | |
#3 | Israel | 4 | |
#4 | Canada | 3 | |
#5 | China | 3 | |
#6 | EPO (European Patent Office) | 3 | |
#7 | Norway | 3 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | Australia | 1 | |
#10 | Hong Kong | 1 | |
#11 | New Zealand | 1 | |
#12 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Auerbach Alan H | 26 |
#2 | Belldegrun Arie S | 25 |
Publication | Filing date | Title |
---|---|---|
US2011021470A1 | Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same | |
WO2009009132A1 | Use of 17alpha-hydroxylase/c17, 20-lyase inhibitors for the treatment of cancer | |
CN101528309A | Methods for treating cancer comprising the administration of a vitamin D compound and an additional therapeutic agent | |
KR20200125776A | Methods and compositions for treating cancer |